Skip to main content
Clinical Trials/NL-OMON50560
NL-OMON50560
Completed
Not Applicable

Reappraisal of Atrial Fibrillation: Interaction between HyperCoagulability, Electrical Remodeling, and Vascular Destabilisation in the Progression of AF - An observational exploratory study on pathophysiological mechanisms of AF progression AND on the role of LinQ/ CareLink guided patient tailored therapy in patients with AF (RACE V) - RACE V

Academisch Medisch Centrum0 sites750 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
atrial fibrillation. Alzheimers disease
Sponsor
Academisch Medisch Centrum
Enrollment
750
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years;
  • Total history \<10 years of paroxysmal, self\-terminating AF;
  • At least one documented episode of AF and 2 symptomatic episodes or two
  • documented episodes, documented as:
  • o AF on ECG, Holter\-recording, loop recorder, event recorder or MyDiagnostic;
  • o Subclinical AF (SCAF) detected in a Medtronic pacemaker (atrial read \> 190
  • bpm lasting \> 6 minutes).
  • Able and willing to sign informed consent for the registry;
  • Able and willing to undergo implantation of ILR (in patients without a CIED);
  • CHA2DS2\-VASc score \<\=5

Exclusion Criteria

  • Non\-self\-terminating, persistent AF;
  • Only AF due to a trigger (i.e. postoperative, due to infection);
  • Congenital heart disease;
  • Refusing to temporarily stop (N)OAC for coagulation phenotyping (in patients
  • already on (N)OAC before inclusion in this study), with the exception for
  • patients with a history of ischemic stroke/ transient ischemic attack;
  • Prior pulmonary vein isolation (PVI) or on waiting list for PVI or expected
  • to be placed on waiting list within one year;
  • Expected to start with, or currently using amiodarone;
  • Pregnancy;

Outcomes

Primary Outcomes

Not specified

Similar Trials